JP2021503610A5 - - Google Patents

Download PDF

Info

Publication number
JP2021503610A5
JP2021503610A5 JP2020545038A JP2020545038A JP2021503610A5 JP 2021503610 A5 JP2021503610 A5 JP 2021503610A5 JP 2020545038 A JP2020545038 A JP 2020545038A JP 2020545038 A JP2020545038 A JP 2020545038A JP 2021503610 A5 JP2021503610 A5 JP 2021503610A5
Authority
JP
Japan
Prior art keywords
protein
biomarker
subject
detecting
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2020545038A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019099732A5 (enExample
JP2021503610A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/061372 external-priority patent/WO2019099732A1/en
Publication of JP2021503610A publication Critical patent/JP2021503610A/ja
Publication of JP2021503610A5 publication Critical patent/JP2021503610A5/ja
Publication of JPWO2019099732A5 publication Critical patent/JPWO2019099732A5/ja
Priority to JP2024001282A priority Critical patent/JP2024038290A/ja
Withdrawn legal-status Critical Current

Links

JP2020545038A 2017-11-16 2018-11-15 神経損傷および／または疾患のタンパク質バイオマーカー指標及びその使用の方法 Withdrawn JP2021503610A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024001282A JP2024038290A (ja) 2017-11-16 2024-01-09 神経損傷および／または疾患のタンパク質バイオマーカー指標及びその使用の方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762587272P 2017-11-16 2017-11-16
US62/587,272 2017-11-16
PCT/US2018/061372 WO2019099732A1 (en) 2017-11-16 2018-11-15 Protein biomarker indicators of neurological injury and/or disease and methods of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024001282A Division JP2024038290A (ja) 2017-11-16 2024-01-09 神経損傷および／または疾患のタンパク質バイオマーカー指標及びその使用の方法

Publications (3)

Publication Number Publication Date
JP2021503610A JP2021503610A (ja) 2021-02-12
JP2021503610A5 true JP2021503610A5 (enExample) 2021-12-23
JPWO2019099732A5 JPWO2019099732A5 (enExample) 2022-09-28

Family

ID=66538796

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020545038A Withdrawn JP2021503610A (ja) 2017-11-16 2018-11-15 神経損傷および／または疾患のタンパク質バイオマーカー指標及びその使用の方法
JP2024001282A Pending JP2024038290A (ja) 2017-11-16 2024-01-09 神経損傷および／または疾患のタンパク質バイオマーカー指標及びその使用の方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024001282A Pending JP2024038290A (ja) 2017-11-16 2024-01-09 神経損傷および／または疾患のタンパク質バイオマーカー指標及びその使用の方法

Country Status (4)

Country Link
US (2) US11988676B2 (enExample)
EP (1) EP3710836A4 (enExample)
JP (2) JP2021503610A (enExample)
WO (1) WO2019099732A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3779448A1 (en) * 2019-08-12 2021-02-17 Baden-Württemberg Stiftung gGmbH Novel diagnostic marker for creutzfeldt-jakob disease and alzheimer's disease
WO2021050880A2 (en) * 2019-09-13 2021-03-18 Northwestern University Biomarkers for amyotrophic lateral sclerosis (als) and motor neuron diseases
US12436154B2 (en) * 2019-09-20 2025-10-07 University Of Florida Research Foundation, Incorporated Detection of antibodies against RAN proteins from serum and tissue lysates
WO2021170659A1 (en) * 2020-02-25 2021-09-02 Markus Otto Diagnosing a disease associated with synaptic degeneration using an elisa for determining a beta-synuclein concentration in csf
JPWO2022176958A1 (enExample) * 2021-02-17 2022-08-25
WO2023092157A1 (en) * 2021-11-22 2023-05-25 Brainbox Solutions, Inc. Biomarker testing for chronic persistent injury following brain trauma
JP7670286B2 (ja) * 2022-06-21 2025-04-30 ａｉｗｅｌｌ株式会社 情報処理システム、特定システムおよびプログラム
WO2024050133A1 (en) * 2022-09-01 2024-03-07 GATC Health Corp Digital twin for diagnostic and therapeutic use
WO2025099851A1 (ja) * 2023-11-08 2025-05-15 ａｉｗｅｌｌ株式会社 情報処理システム、特定システムおよびプログラム

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7427490B2 (en) * 2001-08-20 2008-09-23 Biosite Incorporated Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20120015904A1 (en) * 2010-07-14 2012-01-19 Regents Of The University Of California Biomarkers for diagnosis of transient ischemic attacks
CA2818887A1 (en) * 2010-11-26 2012-05-31 Immunexpress Pty Ltd Diagnostic and/or screening agents and uses therefor
EP2607900A1 (de) * 2011-12-22 2013-06-26 Protagen AG Markersequenzen für Brustkrebs und deren Verwendung
US10809271B2 (en) * 2015-03-27 2020-10-20 The Translational Genomics Research Institute Biomarkers and methods of diagnosing and prognosing mild traumatic brain injuries
EP3292414B1 (en) * 2015-05-05 2021-04-07 The Regents of the University of California Astrocyte traumatome and neurotrauma biomarkers
EP3311176A4 (en) 2015-06-18 2019-03-13 Cedars-Sinai Medical Center ROLE OF CITRULLINATION IN THE DIAGNOSIS OF ILLNESSES
US20170145506A1 (en) * 2015-11-24 2017-05-25 University Of Rochester Signature of Longitudinal Gene Expression Changes to Diagnose Brain Injury

Similar Documents

Publication Publication Date Title
JP2021503610A5 (enExample)
WO2020123316A3 (en) Methods for determining a location of a biological analyte in a biological sample
JP2017522908A5 (enExample)
EP4307310A3 (en) Infection detection and differentiation systems and methods
EP2930578A3 (en) Failure cause classification apparatus
WO2019175876A3 (en) Diagnostic use of cell free dna chromatin immunoprecipitation
GB2556004A (en) Markers of stroke and stroke severity
BR112019005167A2 (pt) método e kit para analisar uma amostra
EP4450636A3 (en) Compositions and methods for enriching populations of nucleic acids
WO2015084985A3 (en) Methods and systems for analyzing image data
EP4230288A3 (en) Programmable arrays
PH12015502849B1 (en) Biomarkers for cognitive dysfunction diseases and method for detecting cognitive dysfunction disease using biomarkers
EP4292654A3 (en) Detection of misfolded proteins
EP3820366C0 (en) BREATH ANALYTE DETECTION DEVICE
EP4365602A3 (en) Stomach cancer biomarker and detection method
BR112019005172A2 (pt) método e kit para analisar uma amostra
EP3592242C0 (en) DEVICE FOR DIAGNOSING BLOOD VESSEL OBSTRUCTION
WO2016127077A3 (en) Systems and methods for detection and analysis of biological species
WO2016205828A3 (en) Role of citrullination in diagnosing diseases
WO2015112558A3 (en) Peptides, devices, and methods for the detection of anaplasma antibodies
MX371298B (es) Métodos y reactivos para la evaluación de diabetes gestacional.
WO2016205637A3 (en) Detection of cerebrospinal fluid
BR112019006862A2 (pt) dispositivo de análise e método para testagem de uma amostra
MX2021002166A (es) Metodos de deteccion basados en acido nucleico.
KR102272812B9 (ko) 생체분자 분석용 나노 플라즈모닉 센서, 키트 및 이를 이용한 생체분자 분석 방법